Navigation Links
Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
Date:5/17/2013

H.A.M.
Kerstjens

Poster Board # H17

Date: Tuesday, May 21
Poster Viewing: 10:45 a.m. - 12:30 p.m. ETNintedanib
Nintedanib is being investigated to determine its efficacy and safety in treating patients with IPF and is not approved for this indication.Title Lead
Author Presentation Details Patient Journey With
Idiopathic Pulmonary
Fibrosis (IPF): A
Breathtaking Experience

C. Conoscenti

Poster Board # 523

Date: Sunday, May 19
Poster Viewing: 8:15 a.m. - 9:15 a.m. ET
Discussion: 9:15 a.m. - 10:45 a.m. ETSustained Inactivation Of
Human Lung Fibroblasts By
Nintedanib

L. Wollin

Poster Board # A32

Date: Monday, May 20
Poster Viewing: 10:45 a.m. - 12:30 p.m. ETAnti-Fibrotic Effects Of
Nintedanib (BIBF 1120) In
Primary Human Lung
Fibroblasts Derived From
Patients With Idiopathic
Pulmonary Fibrosis And
From Non-Fibrotic Controls

K. Hostettler

Poster Board # A28

Date: Monday, May 20
Poster Viewing: 10:45 a.m. - 12:30 p.m. ETNintedanib Reduced Silica-
Induced Lung Inflammation
And Fibrosis In Mice

I. Maillet

Poster Board # 504

Date: Tuesday, May 21
Poster Viewing: 2:00 p.m. - 3:00 p.m. ET
Discussion: 3:00 p.m. - 4:30 p.m. ETOlodaterol and tiotropium + olodaterol
Olodaterol and the combination of tiotropium plus olodaterol are being investigated to determine their efficacy and safety in treating patients with COPD and are not approved for this indication. Title Lead
Author Presentation Details Effects Of Olodaterol And
Tiotropium On
Lipopolysaccharide-
Induced Airway
Hyperresponsiveness And
Inflammation

M. Smit

Poster Board # B41

Date: Sunday, May 19
Poster Viewing: 10:45 a.m. - 12:30 p.m. ETEvaluation Of The Effects
Of The Long-Acting ß2-
Agonist Olodaterol On The
QT And QTc Interval In
H
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015 MEI Pharma, Inc. ... on the clinical development of novel therapies for ... effects of the Company,s investigational drug candidate ME-344 ... when combined with a tyrosine-kinase inhibitor (TKI). In ... be a potent inhibitor of mitochondrial oxidative phosphorylation ...
(Date:5/4/2015)... CONCORD, N.H. , May 4, 2015 /PRNewswire/ ... creating analytic and technology solutions to improve healthcare ... Bedford Nursing & Rehabilitation Center (BNRC) use ... monitoring platform to improve the quality and lower ... analytics platform integrates clinical, outcomes, claims and utilization ...
(Date:5/4/2015)... BOSTON , May 4, 2015 ... appointment of Michael Williams into the ... Mr. Williams is a senior pharmaceutical executive with ... but also long and distinguished service at industry ... His expertise spans a broad range of therapeutic ...
Breaking Medicine Technology:MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 2Geneia Launches First-of-its-Kind Partnership to Use Advanced Analytics to Improve the Quality and Cost of Care for Skilled Nursing and Rehabilitation Patients 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4
... , , , ... HBP; OTCQX: HXBPF) today announced financial results for the first ... HIGHLIGHTS , DOS47/L-DOS47 , Helix announced that a ... Food and Drug Administration ("FDA") in which the FDA generally ...
... ... new market research report is available in its catalogue: , ... , http://www.reportlinker.com/p0164322/Medical-Fiber-Optics---A-World-Market-Analysis.html , Fiber optics work on ... enclosed in an element encased by glass in air of ...
Cached Medicine Technology:Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6
(Date:5/4/2015)... NY (PRWEB) May 04, 2015 Sheltering ... Learning Center from Hale House. The Mother Hale Learning ... high-quality, affordable Early Childhood Education. Sheltering Arms will begin ... continue to be served by the center. , Opened ... children ages six weeks to five years, many of ...
(Date:5/4/2015)... May 04, 2015 New West Medicare ... to Care, LLC to manage outpatient advanced imaging services ... West Medicare ensure its members are provided the right ... , Working closely with New West Medicare’s physicians and ... safe use of advanced imaging and provide an objective ...
(Date:5/4/2015)... 04, 2015 Elisabeth Rosenthal’s article* ... stir and showed the healthcare fraternity as well ... procedure, the downside of balance billing. In definition, ... provider billing a patient for the difference between ... and what the provider chooses to charge. Rosenthal’s ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 In ... US Preventive Services Task Force (USPSTF), Strategic Radiology® ... American Congress of Obstetricians and Gynecologists (ACOG), the ... the Cure, American Cancer Society (ACS), American College ... (SBI) to unanimously recommend regular screening mammography for ...
(Date:5/4/2015)... 2015 World T.E.A.M. Sports’ best-attended ... in the last decade arrived in this historic Civil ... two days from the Pentagon in Arlington, Virginia. The ... disabled and able-bodied participants work together to successfully complete ... honors the commitment and sacrifices by military veterans in ...
Breaking Medicine News(10 mins):Health News:Sheltering Arms Acquires the Mother Hale Learning Center 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 2Health News:Out of Network Balance Billing Without Being Viewed as Fraud 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 2Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 3Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 4Health News:Strategic Radiology® Takes Unified Stance Against New USPSTF Guidelines 5Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 3Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 4
... anthrax attack killed a photo editor has been deemed safe, ... officials. ,Bob Stevens, a photo editor for American ... anthrax in an envelope mailed to the building, which housed ... part of a wave of anthrax attacks and hoaxes that ...
... authorities on Thursday expressed confidence in their efforts to reduce ... of bird flu, after two separate incidents at poultry farms ... not over [for bird flu], but we have sufficient monitoring ... any sporadic cases that might occur," Muhammad Afzal, a spokesman ...
... latest study sleep deprivation could affect the functioning of brain ... from Princeton University. They conducted this study on rats. ... group whose sleep was deprived for 72 hours and the ... of sleep in the first group affected a region in ...
... Johns Hopkins Kimmel Cancer Center scientists have found a ... cells in their primitive state//. Unlocking the switches' code ... cells for transplant into patients with cancer and other ... control switches not at the gene level, but farther ...
... shed on proteorhodopsin, the light-sensitive protein found in many ... Energy’s Lawrence// Berkeley National Laboratory (Berkeley Lab) and the ... the ability to respire oxygen is impaired, bacterium equipped ... out vital life processes. ,“Our research ...
... conducted in 100 pregnant women with anti-Ro and anti-La ... could be treated in early stages//. ,There ... mothers carry particular antibodies associated with rheumatic diseases, according ... researchers at the Society for Maternal-Fetal Medicine Conference February ...
Cached Medicine News:Health News:Pakistan: Authorities Plays Down Bird Flu Risk 2Health News:Master Switches Found for Adult Blood Stem Cells 2Health News:Shedding New Light on Proteorhodopsin 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: